70663-49-9

Upstream product

• 64410-44-2 N-(tert-butoxycarbonyl)-D-alanylglycine benzyl ester 
• 1738-76-7 glycine benzyl ester p-toluenesulfonic acid salt 

Downstream Products

• 64410-47-5 N-(tert-butyloxycarbonyl)-L-tyrosyl-D-alanylglycine 
• 162258-10-8 Boc-Tyr(Bzl)-D-Ala-Gly-N₂H₃ 
• 70961-17-0 Boc-Tyr-D-Ala-Gly-N^α-Me-Phe-OH 
• 162258-11-9 Boc-Tyr(Bzl)-D-Ala-Gly-(Me)Phe-OH 
• 162258-17-5 Boc-Tyr-D-Ala-Gly-(Me)Phe-D-Leu-OH 
• 162258-14-2 Boc-Tyr-D-Ala-Gly-(Me)Phe-Leu-OH 
• 162258-16-4 Boc-Tyr-D-Ala-Gly-(Me)Phe-D-Leu-OBzl 
• 162258-13-1 Boc-Tyr-D-Ala-Gly-(Me)Phe-Leu-OBzl 
• 66959-85-1 Boc-Tyr(Bzl)-D-Ala-Gly-OBzl 

Relevant academic research and scientific papers

Amino acids and peptides. XXIV. Preparation and antinociceptive effect of [D-Ala2, (N-Me)Phe4]enkephalin analog-poly(ethylene glycol) hybrids

Hybrids of amino-poly(ethylene glycol) (aPEG) and [D-Ala2,(N-Me)Phe4]enkephalin analogs, H-Tyr-D-Ala-Gly-(Me)Phe-aPEG, H-Tyr-D-Ala-Gly-(Me)Phe-Leu-aPEG and H-Tyr-D-Ala-Gly-(Me)Phe-D-Leu-aPEG, were prepared by the solution method and

Antiviral Immunotropic Agent for the Treatment of Acute Respiratory Viral Infections

The proposed methods of treatment pertain to medicine, in particular pharmacology, and concerns the application of a nasal medicinal composition containing hexapeptide tyrosyl-D-alanyl-glycyl-phenylalanyl-leucyl-arginine or its pharmaceutically acceptable